Phacilitate Cell and Gene Therapy World 2020, Miami (USA), January 20-24th, 2020

Meet our team at the booth #S20 during Phacilitate Leaders World 2020, in Miami (USA), January 20-24th, 2020.

 

Our solutions for both protein and virus production

PEIpro® is a DNA transfection reagent for production of viruses, recombinant proteins and antibodies either in adherent cells in presence of serum or in suspension HEK-293 cells grown in low serum or serum-free media.

PEIpro®-HQ is a highly qualified grade of PEIpro® reagent, especially developed for the production of clinical batches of recombinant proteins, antibodies or viral vectors. The PEIpro®-HQ grade is supplied with appropriate Quality Controls and documentation allowing its use as a qualified raw material in GMP processes for the manufacturing of clinical batches of therapeutic products.

PEIpro®-GMP (NEW) is the highest quality grade PEI and the only transfection reagent available on the market supplied in a bag, ideal for GMP-compliant closed system manufacturing of clinical grade therapeutic viral vector.

FectoPRO® Transfection kit is specifically designed for enhanced Transient Gene Expression (TGE) in suspension CHO and HEK-293 cells in various serum-free media, using low DNA amount (< 1 µg/ml of cell culture).

FectoCHO™ Expression system is a 3 component kit optimized to work together that contains FectoCHO™ CD Medium, FectoPRO® Transfection Reagent and FectoPRO® Expression Booster. FectoCHO™ Expression System has been developed to reach the highest protein production ever seen in CHO cell lines.

Contact us

 

Talk session

Talk on January 23th, session from 2:35pm to 2:50 pm: “Viral vector manufacturing: securing raw material quality and supplymade by Pascale Belguise, Ph.D, Director of Business Development at Polyplus-transfection.

Pascale Belguise is graduated in Organic Chemistry from the “Lyon Engineer School of Chemistry” (Lyon, France) (1986). Following this degree, Pascale Belguise worked for one year as a Research assistant at the Wayne State University of Detroit (Michigan) on the chemical modification of nucleoside. Then, she received her Ph.D. in Molecular Biology in 1993 from the University of Strasbourg working on the molecular mechanism of mutagenesis in bacteria. In 1996, she joined the Laboratory of Genetic Chemistry, directed by Prof Jean-Paul Behr, as a post-doctoral scientist to work on the targeting of synthetic vectors for gene transfer.

In 2001, Pascale Belguise joined Polyplus-transfection as it was founded. She is directing the Business development, which includes development of new products, management of business partnerships, support of the Gene and Cell Therapy customers and participation to the corporate strategy.

Our team

Meet Pascale, Géraldine & Julien to discuss on how to improve your process of Bioproduction. We will be happy to answer all your questions regarding transfection and to present relevant products adapted to protein or virus production.

General information

The convention took place at Hyatt Regency:

400 SE 2nd Ave, Miami, FL 33131, United States